415 related articles for article (PubMed ID: 21837920)
21. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
[TBL] [Abstract][Full Text] [Related]
22. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT.
Tzankov A; Hittmair A; Müller-Hermelink HK; Rüdiger T; Dirnhofer S
Virchows Arch; 2002 Dec; 441(6):614-7. PubMed ID: 12461620
[TBL] [Abstract][Full Text] [Related]
23. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas.
Brynes RK; Almaguer PD; Leathery KE; McCourty A; Arber DA; Medeiros LJ; Nathwani BN
Mod Pathol; 1996 Oct; 9(10):995-1000. PubMed ID: 8902837
[TBL] [Abstract][Full Text] [Related]
24. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
25. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
26. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
Burke JS
Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
[TBL] [Abstract][Full Text] [Related]
27. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
28. Lymph node hyperplasia: clonal chromosomal and genomic rearrangements. Report of two new cases and literature review.
Villa N; Redaelli S; Lissoni S; Saccheri F; Sala E; Crosti F; Dalprà L; Carrino V; Pioltelli P; Isimbaldi G
Cancer Genet; 2014; 207(1-2):12-8. PubMed ID: 24636528
[TBL] [Abstract][Full Text] [Related]
29. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
30. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
31. Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease.
Arcaini L; Lucioni M; Boveri E; Paulli M
Eur J Haematol; 2009 Sep; 83(3):165-74. PubMed ID: 19548917
[TBL] [Abstract][Full Text] [Related]
32. Childhood nodal marginal zone lymphoma with unusual clinicopathologic and cytogenetic features for the pediatric variant: a case report.
Aqil B; Merritt BY; Elghetany MT; Kamdar KY; Lu XY; Curry CV
Pediatr Dev Pathol; 2015; 18(2):167-71. PubMed ID: 25625642
[TBL] [Abstract][Full Text] [Related]
33. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic features of CD5-positive nodal marginal zone lymphoma.
Jaso JM; Yin CC; Wang SA; Miranda RN; Jabcuga CE; Chen L; Medeiros LJ
Am J Clin Pathol; 2013 Nov; 140(5):693-700. PubMed ID: 24124149
[TBL] [Abstract][Full Text] [Related]
35. B-cell lymphoma with hyaline vascular Castleman disease-like features: a clinicopathologic study.
Siddiqi IN; Brynes RK; Wang E
Am J Clin Pathol; 2011 Jun; 135(6):901-14. PubMed ID: 21571963
[TBL] [Abstract][Full Text] [Related]
36. Indolent lymphomas of mature B lymphocytes.
Kurtin PJ
Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
[TBL] [Abstract][Full Text] [Related]
38. Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens.
Almasri NM; Zaer FS; Iturraspe JA; Braylan RC
Mod Pathol; 1997 Jul; 10(7):650-6. PubMed ID: 9237173
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma.
Sargent RL; Cook JR; Aguilera NI; Surti U; Abbondanzo SL; Gollin SM; Swerdlow SH
Am J Surg Pathol; 2008 Nov; 32(11):1643-53. PubMed ID: 18670352
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
